Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is EuroEyes International Eye Clinic EV-to-FCF?
EuroEyes International Eye ClinicHKSE:01846 +1.22%83 EV-to-FCF is 3.59 as of Aug. 22, 2026, which is 61% below its 10-year median of 9.17. GuruFocus rates HKSE:01846 with a GF Score™ of 83/100 and a GF Value™ of HK$5.59 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 408 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks better than 91.18% on this metric.
HKSE:01846'
s EV-to-FCF Range Over the Past 10 Years
Min: 3.3 Med: 9.17 Max: 118.79
Current: 3.59
During the past 10 years, the highest EV-to-FCF of EuroEyes International Eye Clinic was 118.79. The lowest was 3.30. And the median was 9.17.
HKSE:01846's EV-to-FCF is ranked better than 91.18% of 408
companies
in the Healthcare Providers & Services industry
Industry Median: 18.7
vs HKSE:01846: 3.59
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EuroEyes International Eye Clinic (HKSE:01846) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EuroEyes International Eye Clinic's PE Ratio (TTM) for today is calculated as:
EuroEyes International Eye Clinic's share price for today is HK$2.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
EuroEyes International Eye Clinic EV-to-FCF Related Terms
EuroEyes International Eye Clinic EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's EV-to-FCF falls into.
EuroEyes International Eye Clinic's current Enterprise Value is HK$532.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EuroEyes International Eye Clinic's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$148.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic (HKSE:01846) has a EV-to-FCF of 3.59 as of Aug. 22, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on EuroEyes International Eye Clinic and its competitors. This is 61% below median its historical median of 9.17. Over the past decade, EuroEyes International Eye Clinic's EV-to-FCF has ranged from 3.30 to 118.79. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #36 out of 408 companies in the Healthcare Providers & Services industry, placing it in the top 8.8%.
Is EuroEyes International Eye Clinic's EV-to-FCF too high?
EuroEyes International Eye Clinic's current EV-to-FCF of 3.59 is 61% below median its 10-year median of 9.17. Over the past 10 years, this metric has ranged from a low of 3.30 to a high of 118.79. The Healthcare Providers & Services industry median EV-to-FCF is 18.70. EuroEyes International Eye Clinic's value of 3.59 is 80.8% below this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #36 out of 408 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EuroEyes International Eye Clinic has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #36 out of 408 companies for EV-to-FCF. This places EuroEyes International Eye Clinic in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.70. EuroEyes International Eye Clinic's value of 3.59 is 80.8% below this benchmark. Historically, EuroEyes International Eye Clinic's own EV-to-FCF has ranged from 3.30 to 118.79 over the past decade. While the company's 10-year median is 9.17 vs. the industry median of 18.70, EuroEyes International Eye Clinic has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.70, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current EV-to-FCF of 3.59 is 80.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current EV-to-FCF is 3.59, which is 61% below median its own 10-year median of 9.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.59, compared to a current price of HK$2.48 — trading 55.6% below its estimated fair value. The current EV-to-FCF is 3.59, which is 61% below median its 10-year median of 9.17 and 80.8% below the Healthcare Providers & Services industry median of 18.70. EuroEyes International Eye Clinic's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current EV-to-FCF is 3.59 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.48 is trading 55.6% below its estimated GF Value™ of HK$5.59.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
EV-to-FCF: 3.59 (61% below median its 10-year median of 9.17)
GF Value™: HK$5.59 vs. price of HK$2.48 (55.6% below fair value)
Industry Position: 80.8% below the Healthcare Providers & Services median (#36 of 408)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
83GF Score
Get the complete analysis for HKSE:01846
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
